ADGM
Adagio Medical Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.56
+4.31%Year over year
Reported trailing growth
- Revenue
- -100.0%
- EBITDA
- +66.7%
- EBIT
- +73.0%
- EPS
- +69.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- +7.6%
- EPS
- +28.9%
Three-year CAGR
- Revenue
- -100.0%
- EBITDA
- +60.3%
- EBIT
- +65.0%
- Net income
- +53.3%
- EPS
- +57.3%
- Free cash flow
- +37.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026